Bausch Health Companies (BHC) Return on Invested Capital (2010 - 2026)
Bausch Health Companies (BHC) posted Return on Invested Capital of 0.01% for Q2 2026, up 52.4% sequentially from 0.0% in Q1 2026, and little changed YoY from 0.01% in Q2 2025.
Bausch Health Companies (BHC) Return on Invested Capital (2010 - 2026) Analysis & Trends
Bausch Health Companies has reported Return on Invested Capital for 17 years, with the latest figure at 0.01% in Q2 2026.
- Quarterly Return on Invested Capital changed 0.0% year-over-year to 0.01% in Q2 2026, while the trailing twelve-month figure through Jun 2026 was 0.01% (changed 0.0% YoY) and the FY2025 annual result came in at 0.0%, up 1.0% from the prior year.
- Return on Invested Capital improved to 0.01% in Q2 2026 per BHC's latest filing, from 0.0% in the prior quarter.
- Over five years, Return on Invested Capital peaked at 0.03% in Q3 2022 and troughed at 0.03% in Q2 2023.
- A 5-year average of 0.01% and a median of 0.0% in 2026 frame the typical range for Return on Invested Capital.
- The sharpest annual moves came in 2023 and 2024: Return on Invested Capital declined 3 bps in 2023, then grew 4 bps in 2024.
- Over 5 years, Return on Invested Capital stood at 0.01% in 2022, then decreased by 16 bps to 0.01% in 2023, then slumped by 127 bps to 0.0% in 2024, then surged by 184 bps to 0.0% in 2025, then soared by 177 bps to 0.01% in 2026.
- According to Business Quant data, Return on Invested Capital over the past three periods registered 0.01%, 0.0%, and 0.0% for Q2 2026, Q1 2026, and Q4 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROIC (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.83 Bn | 42.86 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 42.87 Bn | 39.22 Bn | 2.15 Bn | 0.00% |
| 3 | Zoetis | 31.41 Bn | 29.73 Bn | 1.05 Bn | - |
| 4 | Takeda Pharmaceutical | 28.55 Bn | 22.75 Bn | 5.10 Bn | 0.00% |
| 5 | United Therapeutics | 22.08 Bn | 19.42 Bn | 683.80 Mn | - |
| 6 | Viatris | 18.73 Bn | 17.84 Bn | 1.46 Bn | 0.00% |
| 7 | Neurocrine Biosciences | 15.44 Bn | 15.05 Bn | 935.80 Mn | - |
| 8 | Elanco Animal Health | 11.75 Bn | 11.22 Bn | 798.00 Mn | 0.03% |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.94 Bn | - | - |
| 10 | Bausch Health Companies | 2.56 Bn | 725.13 Mn | 2.10 Bn | 0.01% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 0.01% |
| Mar 31, 2026 | 0.00% |
| Dec 31, 2025 | 0.00% |
| Sep 30, 2025 | 0.00% |
| Jun 30, 2025 | 0.00% |
| Mar 31, 2025 | 0.00% |
| Dec 31, 2024 | 0.00% |
| Sep 30, 2024 | 0.03% |
| Jun 30, 2024 | 0.01% |
| Mar 31, 2024 | 0.01% |
| Dec 31, 2023 | 0.01% |
| Sep 30, 2023 | 0.00% |
| Jun 30, 2023 | -0.03% |
| Mar 31, 2023 | 0.01% |
| Dec 31, 2022 | 0.01% |
| Sep 30, 2022 | 0.03% |
| Mar 31, 2021 | 0.52% |
| Dec 31, 2020 | 0.01% |
| Sep 30, 2020 | 0.00% |
| Jun 30, 2020 | 0.00% |